Aspen Aerogels (NYSE:ASPN – Get Free Report) is expected to be releasing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Aspen Aerogels to post earnings of ($0.09) per share and revenue of $72.07 million for the quarter. Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.
Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The business had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%. On average, analysts expect Aspen Aerogels to post ($0.69) EPS for the current fiscal year and ($0.21) EPS for the next fiscal year.
Aspen Aerogels Price Performance
ASPN opened at $4.97 on Wednesday. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. The business has a 50 day simple moving average of $5.24 and a 200-day simple moving average of $4.68. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $8.10.
Analyst Ratings Changes
ASPN has been the topic of a number of recent analyst reports. Wall Street Zen raised Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday. B. Riley Financial reiterated a “buy” rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, September 21st. Barclays boosted their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 11th. Finally, Roth Capital reaffirmed a “buy” rating and set a $7.75 price target on shares of Aspen Aerogels in a research note on Friday, August 7th. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $5.94.
View Our Latest Research Report on ASPN
Insider Activity
In other news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of Aspen Aerogels stock in a transaction that occurred on Wednesday, September 23rd. The shares were sold at an average price of $4.73, for a total transaction of $58,086,414.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.96% of the company’s stock.
About Aspen Aerogels
Aspen Aerogels, Inc is an advanced materials company that develops, manufactures and sells aerogel-based products. Aerogels are highly porous materials used for thermal management, insulation and protection. The company serves customers in the energy, industrial, transportation and building materials markets.
Its product portfolio includes thermal barriers designed to help protect electric vehicle batteries from thermal runaway, as well as insulation products for industrial, energy infrastructure and building applications.
Read More
- Five stocks we like better than Aspen Aerogels
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.
